JP2001515029A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515029A5
JP2001515029A5 JP2000509400A JP2000509400A JP2001515029A5 JP 2001515029 A5 JP2001515029 A5 JP 2001515029A5 JP 2000509400 A JP2000509400 A JP 2000509400A JP 2000509400 A JP2000509400 A JP 2000509400A JP 2001515029 A5 JP2001515029 A5 JP 2001515029A5
Authority
JP
Japan
Prior art keywords
dosage form
polymer
form according
soluble
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000509400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001515029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/015693 external-priority patent/WO1999008660A1/en
Publication of JP2001515029A publication Critical patent/JP2001515029A/ja
Publication of JP2001515029A5 publication Critical patent/JP2001515029A5/ja
Abandoned legal-status Critical Current

Links

JP2000509400A 1997-08-21 1998-07-29 粒状分散形態の固形医薬剤形 Abandoned JP2001515029A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5619597P 1997-08-21 1997-08-21
US60/056,195 1997-08-21
PCT/US1998/015693 WO1999008660A1 (en) 1997-08-21 1998-07-29 Solid pharmaceutical dosage forms in form of a particulate dispersion

Publications (2)

Publication Number Publication Date
JP2001515029A JP2001515029A (ja) 2001-09-18
JP2001515029A5 true JP2001515029A5 (cg-RX-API-DMAC10.html) 2006-01-05

Family

ID=22002810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000509400A Abandoned JP2001515029A (ja) 1997-08-21 1998-07-29 粒状分散形態の固形医薬剤形

Country Status (17)

Country Link
US (1) US20010048946A1 (cg-RX-API-DMAC10.html)
EP (1) EP1011640A1 (cg-RX-API-DMAC10.html)
JP (1) JP2001515029A (cg-RX-API-DMAC10.html)
KR (1) KR20010023085A (cg-RX-API-DMAC10.html)
AR (1) AR018252A1 (cg-RX-API-DMAC10.html)
AU (1) AU8600098A (cg-RX-API-DMAC10.html)
BR (1) BR9811972A (cg-RX-API-DMAC10.html)
CA (1) CA2292586C (cg-RX-API-DMAC10.html)
CO (1) CO4960652A1 (cg-RX-API-DMAC10.html)
GT (1) GT199800136A (cg-RX-API-DMAC10.html)
HN (1) HN1998000115A (cg-RX-API-DMAC10.html)
NZ (1) NZ502869A (cg-RX-API-DMAC10.html)
PA (1) PA8458101A1 (cg-RX-API-DMAC10.html)
PE (1) PE109599A1 (cg-RX-API-DMAC10.html)
SV (1) SV1998000104A (cg-RX-API-DMAC10.html)
WO (1) WO1999008660A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA987551B (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
JPH06511291A (ja) * 1991-08-02 1994-12-15 ウィルコム タフティング ピーティーワイ リミテッド 房付け方法及び房付けシステム
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
YU43702A (sh) 1999-12-23 2004-11-25 Pfizer Products Inc. Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
ATE293439T1 (de) * 2000-12-07 2005-05-15 Warner Lambert Co Verfahren und system zur gleichmä igen arzneistoffabgabe
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
CN1681479A (zh) * 2002-08-12 2005-10-12 辉瑞产品公司 半有序药物和聚合物的药物组合物
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
GB0315012D0 (en) * 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
US8273371B2 (en) * 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1817008B1 (en) 2004-11-09 2020-04-01 Board of Regents, The University of Texas System Stabilized hme composition with small drug particles
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
DK1830817T3 (da) * 2004-12-30 2013-04-02 Pf Medicament Stabil, fast dispersion af et derivat af vinca-alkaloid og fremgangsmåde til fremstilling heraf
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
NZ585116A (en) * 2005-05-10 2011-12-22 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds e.g. metformin hydrochloride
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
JP2010513324A (ja) * 2006-12-21 2010-04-30 アルファファーム ピーティーワイ リミテッド 医薬化合物および医薬組成物
PT2309987E (pt) * 2008-07-03 2012-12-13 Novartis Ag Processo para granulação por fusão
WO2010136604A1 (en) * 2009-05-29 2010-12-02 Dsm Ip Assets B.V. Transfer matrix for transferring a bioactive agent to body tissue
CN103391769A (zh) 2011-02-17 2013-11-13 霍夫曼-拉罗奇有限公司 通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法
CA2848493A1 (en) 2011-09-14 2013-03-21 Celgene Corporation Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
JPH054919A (ja) * 1990-07-25 1993-01-14 Sankyo Co Ltd チアゾリジン誘導体の固体分散体
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
JPH07324086A (ja) * 1994-05-31 1995-12-12 Sankyo Co Ltd チアゾリジン誘導体の固体分散体または固体分散体製剤
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung

Similar Documents

Publication Publication Date Title
JP2513999B2 (ja) 口腔又は鼻腔用医薬組成物
JP3496961B2 (ja) 有効成分を徐放するための多層マトリックス系
AU719170B2 (en) Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids
CO4960652A1 (es) Formas de dosificacion farmaceuticas solidas
BG66095B1 (bg) Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат
CA2301378A1 (en) Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
MA25323A1 (fr) Formes galeniques a delitement rapide en bouche et leur procede de preparation.
TR200003788A2 (tr) Yavaş salımlı oral dozaj bileşim.
CR7661A (es) Composicion de comprimido de liberacion sostenida de pramipexol
CA2204180A1 (en) Melt-extruded orally administrable therapeutically active formulations
DE69726179D1 (de) Pharmazeutische suspensionssysteme
DE69330672D1 (de) Pharmazeutische zubereitung zur anwendung in den atemwegen
EP1797873A3 (en) Compressed microparticles for dry injection
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
IT1270239B (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
WO2002024203A3 (en) Controlled release formulations for oral administration
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
WO2001013898A3 (en) Pharmaceutical formulations with different release times
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
RU2002112238A (ru) Перорально распадающаяся композиция, содержащая миртазапин
AP2001002084A0 (en) Orally administered controlled delivery system for once daily adminstration of ciprofloxacin
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
AU2127400A (en) A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof